←
Michael Fox4,906 posts
Michael Fox avatar

Michael Fox

@foxmdphd

Neurology Prof and Neuroscientist focused on brain imaging and brain stimulation @harvardmed @brighamWomens @brain_circuits

◷ Joined July 2018▧ 273 Photos and videos
Deng Pan 潘登 avatar
⟳ Michael Fox retweeted
Deng Pan 潘登@DengPan18·Nov 17

Our work is now published @NatureHumBehav We hope TUS can be a game-changer for bridging the gap between high-level cognition and its neural basis in healthy humans by enabling causal tests of deep-brain structures such as the hippocampus. nature.com/articles/s41562-0… Preview:

6:55

🚨We believe this is a major step forward in how we study hippocampus function in healthy humans. Using novel behavioral tasks, fMRI, RL & RNN modeling, and transcranial ultrasound stimulation (TUS), we demonstrate the causal role of hippocampus in relational structure learning.

Post attachment
Martijn Arns avatar
⟳ Michael Fox retweeted
Martijn Arns@Brainclinics·Oct 20

Using Heart-Brain Coupling as a prefrontal grid search procedure for TMS yielded HBC in 90% of subjects, most often a non-BeamF3 site. Beyond Beam-F3: A Grid-Based Frontal Mapping Approach using Heart-Brain Coupling to Guide Personalized Non-Invasive Brain Stimulation sciencedirect.com/science/ar… Congrats Jessica Jacobs, great work!

Michelle Monje 🟦 avatar
⟳ Michael Fox retweeted
Michelle Monje 🟦@michelle_monje·Sep 20

Brain cancers take advantage of neural circuit activity. Re-purposing an anti-seizure med called levetiracetam disrupts an important neuron-cancer interaction in #DMG #DIPG, slowing growth and extending survival in mice and retrospective patient data. nature.com/articles/s41591-0…

MGB Neurosurgery avatar
⟳ Michael Fox retweeted
MGB Neurosurgery@MGBneurosurgery·Sep 21

Congratulations to Dr. G. Rees Cosgrove on being selected by the WSSFN leadership to receive the 2026 Tasker Award. The Ronald Tasker Award is a distinguished achievement honor presented by the World Society for Stereotactic and Functional Neurosurgery (WSSFN) to highly accomplished functional neurosurgeons.

Post attachment
Andrew Zalesky avatar
⟳ Michael Fox retweeted
Andrew Zalesky@AndrewZalesky·Aug 22

Structural vs functional connectivity-guided accelerated iTBS in MDD SC-guided iTBS produced promising preliminary evidence of improved antidepressant response compared with 5-cm targeting, supporting sgACC-based connectivity-guided precision TMS psychiatryonline.org/doi/10.…

Post attachment
BD² avatar
⟳ Michael Fox retweeted
BD²@BD2Discoveries·Aug 3

🧠Great to see the BD² community at NYC Neuromodulation 2026—sharing ideas, connecting across the field, and bringing our neuromodulation teams together.

Post attachment
Can SARICA avatar
⟳ Michael Fox retweeted
Can SARICA@CANSARICA2·Aug 4

What a fantastic weekend at 2026 #NYC #Neuromodulation #Conference, without a doubt one of the best neuromodulation conferences of the year! It was a pleasure to attend with a wonderful team from @Brain_Circuits. Huge congratulations to @foxmdphd, @shansiddiqi, @PinesAndrew, @b_hollunder, Samantha Baldi, and @NaN_Value for their outstanding talks and insightful panel discussions. It was also great to reunite with my former @UofTNeuroSurge researcher colleagues, Ghazaleh Darmani and @HamidRamezanpou, who both delivered excellent presentations. An especially exciting moment was seeing Ghazel receive the prestigious Zabara Foundation #EarlyCareerAward with #focusedultrasound research, an incredibly well-deserved recognition. Congratulations! A big thank you to the entire @neuromodec organizing committee, especially @MaromBikson, @allisoncwaters, Elisa Kallioniemi, and Renée Hartig, for putting together such an outstanding meeting. I'm already looking forward to next conference!

Post attachmentPost attachmentPost attachmentPost attachment
Matt Burke avatar
⟳ Michael Fox retweeted
Matt Burke@MattBurkeMD·Aug 18

Massive study published yesterday in @NatureHumBehav for anyone in the neuropsychiatry/mind-brain-behavior spaces Direct in vivo evidence for how attention can modulate the immune system in ways that seem almost unbelievable nature.com/articles/s41562-0…

Amit Etkin avatar
⟳ Michael Fox retweeted
Amit Etkin@AmitEtkin·Aug 18

Great summary of the recent PRIME-PRAXOL @NatureMedicine trial results showing profound anti-anhedonic activity of pramipexole.

🚨 A Parkinson's drug just showed clear efficacy for anhedonic depression. In a new RCT, the dopamine agonist pramipexole significantly improved the ability to feel pleasure, increased physical activity, and engaged the brain's reward circuit. Move aside serotonin🧵

Post attachment
Foundation for the National Institutes of Health avatar
⟳ Michael Fox retweeted
Foundation for the National Institutes of Health@FNIH_Org·Jul 29

For years, depression has been diagnosed as a single disease based on symptoms – yet the underlying causes can vary from person to person. FNIH is launching the first phase of a long-term study that will collect data across a broad set of measures to identify biomarkers and more clearly define depression subtypes. This will pave the way for more individualized care for the nearly 21 million U.S. adults who experience a major depressive episode each year.  Learn more: fnih.org/press-release/fnihs… #PrecisionMedicine #MAP-D #BridgestoBreakthroughs #Depression #BiomarkerScience

Post attachment
Brain avatar
⟳ Michael Fox retweeted
Brain@Brain1878·Jul 3

Using disconnectome analyses in stroke patients with aphasia, Ito et al. find that distinct neural pathways underlie writing deficits in kana (phonograms) and kanji (morphograms). shorturl.at/SEqWT

Post attachment
Eric Topol avatar
⟳ Michael Fox retweeted
Eric Topol@EricTopol·Jul 2

The cancer-Alzheimer's paradox, an inverse correlation, with an unexplained mechanism "The risk of Alzheimer’s disease in patients with cancer is significantly reduced, and the risk of cancer in patients with Alzheimer’s disease is halved." nature.com/articles/s41514-0…

Michael Fox avatar
Michael Fox@foxmdphd·Jun 25

Is brain circuit targeted TMS better at treating depression than scalp targeted TMS? New paper by Joe Taylor @Brain_Circuits out today in @JAMAPsych says yes! Connectivity- vs Scalp-Based Targeting of Accelerated TMS for Depression jamanetwork.com/journals/jam…

Shan Siddiqi @shansiddiqi.bsky.social avatar
⟳ Michael Fox retweeted
Shan Siddiqi @shansiddiqi.bsky.social@shansiddiqi·Jun 24

We all thought this study would fail, for different reasons. Joe Taylor (1st author) thought it'd be a takedown of fMRI-guided TMS. @foxmdphd and I (co-senior authors) thought the effect would be too small to detect in just 40 patients. We were wrong. jamanetwork.com/journals/jam…